Get the Stockscreener App
4.42
8.87%
-0.43
After Hours:
4.48
0.06
+1.36%
Turn Therapeutics Inc stock is traded at $4.42, with a volume of 127.97K.
It is down -8.87% in the last 24 hours and up +0.00% over the past month.
Turn Therapeutics Inc is a pharmaceutical and medical device development company built around a proprietary platform technology designed to enhance drug performance. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble APIs in oil-based carriers without the use of emulsifiers. This innovation reduces the quantity of required API inclusion by improving its bioavailability. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis.
See More
Previous Close:
$4.85
Open:
$4.78
24h Volume:
127.97K
Relative Volume:
0.36
Market Cap:
$135.91M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-11.07%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$4.40
$4.8435
1-Week Range:
$4.40
$5.58
52-Week Range:
$4.07
$26.50
Turn Therapeutics Inc Stock (TTRX) Company Profile
Compare TTRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TTRX
Turn Therapeutics Inc
|
4.42 | 135.91M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Turn Therapeutics Inc Stock (TTRX) Latest News
TTRX News Today | Why did Turn Therapeutics stock go down today? - MarketBeat
Turn Therapeutics (TTRX) Stock Trends and Sentiment 2025 - MarketBeat
Turn Therapeutics (TTRX) Competitors and Alternatives 2025 - MarketBeat
Turn Therapeutics (TTRX) Stock Chart and Price History 2025 - MarketBeat
Turn Therapeutics signs license deal with surgical product supplier Medline - MSN
Turn Therapeutics partners with Medline for global supply agreement By Investing.com - Investing.com Australia
Turn Therapeutics Partners with Medline for Global Expansion - TipRanks
Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline - Yahoo Finance
Turn Therapeutics (TTRX) Stock Price, News & Analysis - MarketBeat
Turn Therapeutics (NASDAQ:TTRX) Insider Purchases $65,715.60 in Stock - Defense World
Turn Therapeutics appoints Kester to board of directors - MSN
Form 424B5 Turn Therapeutics Inc. - StreetInsider
What is the current Price Target and Forecast for Turn Therapeutics Inc. (TTRX) - Zacks Investment Research
Should I buy Turn Therapeutics Inc. (TTRX) - Zacks Investment Research
Insider Stock Purchases: October 24, 2025 - Quiver Quantitative
Strength Seen in Cartesian Therapeutics, Inc. (RNAC): Can Its 8.2% Jump Turn into More Strength? - MSN
Insider Buying: Arthur Golden Acquires 20,202 Shares of Turn The - GuruFocus
Turn therapeutics officer Chaudhary buys $24,997 in shares By Investing.com - Investing.com Philippines
Turn Therapeutics director Golden buys $100k in shares - Investing.com
Turn therapeutics officer Chaudhary buys $24,997 in shares - Investing.com
Turn Therapeutics Updates Shareholders on Clinical Progress - TipRanks
Turn Therapeutics provides shareholder update on clinical program progress - TipRanks
Turn Therapeutics provides shareholder update highlighting continued execution across clinical and strategic milestones - MarketScreener
Turn Therapeutics Provides Shareholder Update on Clinical Progress and Capital Strategy - Quiver Quantitative
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones - TradingView
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical ... - Bluefield Daily Telegraph
Can Karyopharm Therapeutics Inc. (25K0) stock ride next bull market cycle2025 Growth vs Value & Daily Market Momentum Tracking - nchmf.gov.vn
Turn Therapeutics launches webinar series for shareholder engagement - MSN
Will Serina Therapeutics Inc. stock beat value stocksJuly 2025 Rallies & Low Drawdown Trading Techniques - nchmf.gov.vn
Is Knight Therapeutics Inc. (04K) stock a good hedge against inflationWeekly Stock Recap & Fast Gain Swing Trade Alerts - nchmf.gov.vn
Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025 - MarketScreener
Earnings Recap: Is Palvella Therapeutics Inc. (PI6) stock a contrarian opportunity2025 Key Lessons & Precise Buy Zone Tips - nchmf.gov.vn
Will Atossa Therapeutics Inc. (YAG2) stock outperform Dow JonesWeekly Risk Report & Consistent Profit Trade Alerts - nchmf.gov.vn
Biotech Firm Turn Therapeutics Goes Public - Los Angeles Business Journal
Will Advanced Proteome Therapeutics Corporation (0E81) stock gain from green policiesJuly 2025 Drop Watch & Smart Allocation Stock Tips - nchmf.gov.vn
Published on: 2025-10-19 02:06:54 - nchmf.gov.vn
Can Maze Therapeutics Inc. stock deliver sustainable ROEJuly 2025 Action & Real-Time Stock Price Movement Reports - nchmf.gov.vn
Layoff Watch: What risks investors should watch in AN2 Therapeutics Inc. stock2025 Top Decliners & Target Return Focused Picks - Trung tâm Dự báo KTTV quốc gia
Is Fulcrum Therapeutics Inc. stock a good choice for value investors2025 Trade Ideas & Weekly Chart Analysis and Trade Guides - nchmf.gov.vn
Is Zevra Therapeutics Inc. stock a smart buy before Fed meeting2025 Earnings Impact & Advanced Swing Trade Entry Alerts - nchmf.gov.vn
Stock Report: Will Mersana Therapeutics Inc. stock keep outperforming rivalsMarket Trend Summary & Safe Capital Growth Stock Tips - nchmf.gov.vn
Can CERo Therapeutics Holdings Inc. Equity Warrant stock surprise with earnings upsideJuly 2025 Summary & Safe Entry Point Identification - Trung tâm Dự báo KTTV quốc gia
Can Ernexa Therapeutics Inc. stock sustain market leadershipQuarterly Growth Report & Growth Focused Investment Plans - nchmf.gov.vn
Pullback Watch: Will Madrigal Pharmaceuticals Inc. stock benefit from upcoming earnings reports2025 Price Action Summary & AI Forecasted Entry/Exit Points - nchmf.gov.vn
Volatility Watch: Will Unicycive Therapeutics Inc. stock gain from lower inflationNew Guidance & Safe Entry Momentum Stock Tips - Trung tâm Dự báo KTTV quốc gia
Will Relay Therapeutics Inc. stock benefit from commodity prices2025 Buyback Activity & Fast Momentum Entry Tips - nchmf.gov.vn
Evaluating Pliant Therapeutics Inc. with trendline analysisJuly 2025 Decliners & Fast Entry Momentum Alerts - newser.com
Published on: 2025-10-18 11:14:04 - nchmf.gov.vn
Will TG Therapeutics Inc. stock reach all time highs in 2025Quarterly Profit Report & Safe Entry Trade Reports - nchmf.gov.vn
Best data tools to analyze Spyre Therapeutics Inc. stockQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Is Astria Therapeutics Inc. stock supported by strong fundamentalsChart Signals & Low Risk Entry Point Tips - Trung tâm Dự báo KTTV quốc gia
Turn Therapeutics Inc Stock (TTRX) Financials Data
There is no financial data for Turn Therapeutics Inc (TTRX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):